Join forces with us in creation of NEXT GENERATION MEDICINES


Nuevolution is a leading company in the research & development of small molecule (tablet) based medicines for the treatment of cancer and severe inflammatory diseases.

Nuevolution embraces long term partnerships to advance several novel and promising drug programs through clinical development towards commercialization, addressing unmet medical need and supporting the best options for patient treatment. Nuevolution is interested in partnerships around its inflammatory disease and cancer programs with companies who are keen on working together with Nuevolution to swiftly progress programs to the market.


Nuevolution is the pioneer and leader within the field of applying DNA-encoded technology in the development of novel and attractive small molecule drug programs. With 17 years of research experience, supported by the unique drug discovery platform, Nuevolution is the ideal partner for establishing drug discovery partnerships.

Together with our partners, we have been successful in many collaborations. Nuevolution is willing to engage in risk sharing collaborations as well as joint-venture collaborations where the work efforts are shared between partners, to facilitate moving drug program swiftly forward.